First Trust Advisors LP Increases Position in Tenet Healthcare Corporation $THC
First Trust Advisors LP boosted its holdings in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 11. 8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 240,019 shares of the company's s
First Trust Advisors LP boosted its holdings in shares of Tenet Healthcare Corporation (NYSE:THC-Free Report) by 11. 8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 240,019 shares of the company's stock after purchasing an additional 25,263 shares during the quarter. First Trust Advisors LP owned approximately 0. 28% of Tenet Healthcare worth $45,294,000 at the end of the most recent reporting period. Top Analyst-Rated Healthcare Stocks to Watch NowA number of other institutional investors and hedge funds have also made changes to their positions in the business. Triumph Capital Management acquired a new position in Tenet Healthcare during the third quarter worth $25,000. Activest Wealth Management acquired a new position in shares of Tenet Healthcare during the 4th quarter worth about $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the 4th quarter worth about $29,000. Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare during the 2nd quarter worth approximately $35,000. Finally, Meeder Asset Management Inc. raised its holdings in shares of Tenet Healthcare by 146. 2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company's stock valued at $38,000 after acquiring an additional 114 shares during the last quarter. 95. 44% of the stock is currently owned by hedge funds and other institutional investors. GetTenet Healthcarealerts:Analyst Ratings ChangesA number of analysts have recently issued reports on THC shares. Guggenheim lowered their price target on Tenet Healthcare from $252. 00 to $242. 00 and set a "buy" rating on the stock in a research note on Monday, July 20th. Stephens decreased their price objective on Tenet Healthcare from $275. 00 to $260. 00 and set an "overweight" rating on the stock in a report on Monday, May 4th. Royal Bank Of Canada lowered their target price on shares of Tenet Healthcare from $277. 00 to $236. 00 and set an "outperform" rating on the stock in a research note on Friday, May 1st. UBS Group reiterated a "buy" rating on shares of Tenet Healthcare in a research report on Friday. Finally,Weiss Ratingslowered shares of Tenet Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Tuesday, June 2nd. Seventeen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $246. 47. 3 Under-the-Radar Healthcare CompaniesCheck Out Our Latest Report on Tenet HealthcareInsider ActivityIn related news, DirectorJ Robert Kerreysold 5,638 shares of the company's stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174. 52, for a total value of $983,943. 76. Following the transaction, the director directly owned 16,804 shares in the company, valued at approximately $2,932,634. 08. This represents a 25. 12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible throughthis link. Also, DirectorNadja Westsold 3,000 shares of the firm's stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177. 35, for a total value of $532,050. 00. Following the sale, the director directly owned 24,805 shares of the company's stock, valued at approximately $4,399,166. 75. This trade represents a 10. 79% decrease in their position. TheSEC filingfor this sale provides additional information. Insiders own 0. 97% of the company's stock. Trending Headlines about Tenet HealthcareHCA Healthcare: Temporary Setbacks, Long-Term StrengthHere are the key news stories impacting Tenet Healthcare this week:Positive Sentiment:Tenet beat Q2 expectations by a wide margin, reporting$6. 12 EPSversus estimates around$4. 26, while revenue of$6. 04 billionalso came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial OutlookPositive Sentiment:Management raised FY 2026 EPS guidance to$20. 30-$21. 69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial OutlookPositive Sentiment:Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major UpgradeNeutral Sentiment:Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call TranscriptNeutral Sentiment:Media coverage also noted broader strength in hospital stocks, which may be adding to the move inTenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring TodayTenet Healthcare Stock PerformanceNYSE THCopened at $233. 10 on Monday. Tenet Healthcare Corporation has a fifty-two week low of $146. 60 and a fifty-two week high of $247. 21. The firm has a market capitalization of $20. 08 billion, a P/E ratio of 8. 99, a price-to-earnings-growth ratio of 1. 61 and a beta of 1. 27. The stock's fifty day moving average is $185. 16 and its two-hundred day moving average is $197. 55. The company has a debt-to-equity ratio of 2. 00, a quick ratio of 1. 35 and a current ratio of 1. 41. Tenet Healthcare (NYSE:THC-Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $6. 12 EPS for the quarter, topping the consensus estimate of $4. 26 by $1. 86. Tenet Healthcare had a return on equity of 26. 76% and a net margin of 10. 27%. The business had revenue of $6. 04 billion for the quarter, compared to analyst estimates of $5. 43 billion. During the same quarter in the previous year, the firm earned $4. 02 EPS. The company's quarterly revenue was up 6. 8% compared to the same quarter last year. On average, research analysts anticipate that Tenet Healthcare Corporation will post 21 earnings per share for the current year. About Tenet Healthcare(Free Report)Tenet Healthcare CorporationNYSE: THCis a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics. In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination. Recommended StoriesFive stocks we like better than Tenet HealthcareRTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?These 4 Earnings Reports Expose the Market’s Growing Economic DivideBroadcom May Be the Biggest Winner From Alphabet's EarningsVolatility Is Back and These 3 Market Tollbooths Are Best Positioned to ProfitThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Should You Invest $1,000 in Tenet Healthcare Right Now?Before you consider Tenet Healthcare, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Tenet Healthcare wasn't on the list. While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereEnter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report